Sacubitril valsartan sodium hydrate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
170 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | HP_0001635 | I50 | 4 | 15 | 18 | 40 | 28 | 101 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 14 | 14 | 6 | 3 | 36 |
| Essential hypertension | D000075222 | — | I10 | — | 5 | 6 | 1 | — | 12 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | 3 | 3 | 1 | 8 |
| Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | 1 | 3 | 3 | 7 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | 3 | 2 | 1 | 7 |
| Hypertrophy | D006984 | EFO_0002460 | — | — | 4 | 1 | 1 | — | 5 |
| Left ventricular dysfunction | D018487 | — | — | — | 1 | 1 | 1 | 1 | 4 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 3 | 1 | 1 | — | 4 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 2 | 1 | 1 | 1 | 4 |
Show 30 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ventricular remodeling | D020257 | — | — | — | 2 | 2 | — | 2 | 6 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | 3 | 3 | — | — | 5 |
| Systolic murmurs | D054160 | — | R01.1 | — | 1 | 2 | — | 1 | 4 |
| Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | 3 | 1 | — | — | 3 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 1 | — | 1 | 3 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | 1 | 1 | — | — | 3 |
| Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | 1 | — | 1 | 2 |
| Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | 1 | 1 | — | 1 | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | 1 | — | — | 1 |
| Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | — | 1 | — | — | 1 |
Show 7 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | 1 | — | — | — | 3 |
| Atrial remodeling | D064752 | — | — | — | 1 | — | — | 1 | 2 |
| Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | 2 | — | — | — | 2 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 2 | — | — | — | 2 |
| Chronic renal insufficiency | D051436 | — | N18 | 2 | 1 | — | — | — | 2 |
| Myositis | D009220 | EFO_0000783 | G72.49 | — | 1 | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | 1 | — | — | — | 1 |
| Insulin resistance | D007333 | HP_0000855 | — | — | 1 | — | — | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 1 | — | — | — | 1 |
Show 12 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
| Papillary thyroid cancer | D000077273 | — | — | 1 | — | — | — | — | 1 |
| Thyroid diseases | D013959 | HP_0000820 | E00-E07 | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
| Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
| Cardio-renal syndrome | D059347 | — | — | — | — | — | — | 1 | 1 |
| Univentricular heart | D000080039 | — | Q20.4 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 17 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
51 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use